BioPharma Resources

Investigational drug · Phase 2

UC-MSC

Also called: RY_SW01 cell, Human umbilical cord mesenchymal stem cells, umbilical cord mesenchymal stem cell

Not approved by FDA. In 8 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1.

Phase 2

Last checked: Nov 19, 2026Latest source record: Aug 14, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

8

8 still active

All registered trials

94

Any phase or sponsor naming "UC-MSC"

First trial start

2023

Jul 30, 2023

Conditions studied

As listed on its trial records.

  • Acute Respiratory Distress Syndrome
  • Lupus Nephritis
  • Spinocerebellar Ataxia Type 1
  • Spinocerebellar Ataxia Type 2
  • Spinocerebellar Ataxia Type 3
  • Spinocerebellar Ataxia Type 6
  • Decompensated Liver Cirrhosis
  • Decompensated Hepatitis B Cirrhosis
  • Arteriovenous Fistula Stenosis
  • Systemic Sclerosis

Approved drugs for the same conditions: Lupus (SLE) · Hepatitis B · Neurology · Immunology and inflammation · Infectious disease and vaccines · Rare and genetic disease · Kidney and urology · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "UC-MSC" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 2,597 on PubMed

Also in development for Acute Respiratory Distress Syndrome

  • STSA-1002Phase 32 trials

    Staidson (Beijing) Biopharmaceuticals Co., Ltd · Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Distress Syndrome

  • AtibuclimabIC14Phase 24 trials

    Implicit Bioscience · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury

  • SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials

    PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke

  • paridiprubartPhase 22 trials

    PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)

  • rhu-pGSNrecombinant human gelsolin, Recombinant human plasma gelsolin pre-exposurePhase 22 trials

    BioAegis Therapeutics Inc. · Acute Respiratory Distress Syndrome, Infections, Decompression Sickness

  • vilobelimabPhase 22 trials

    PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)

  • AV-001Phase 21 trial

    Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.